AIM - AIM ImmunoTech GAAP EPS of -$0.13 misses by $0.01 November, 15 2022 07:39 AM AIM ImmunoTech Inc. AIM ImmunoTech press release ( NYSE: AIM ): Q3 GAAP EPS of -$0.13 misses by $0.01 . Cash and cash equivalents of $36.7M, expected to fund operations through end of 2023. For further details see: AIM ImmunoTech GAAP EPS of -$0.13 misses by $0.01